Literature DB >> 32981904

Late-diagnosed cesarean scar pregnancy resulting in unexpected placenta accreta spectrum necessitating hysterectomy.

Nanao Suzuki1, Hyo Kyozuka1, Toma Fukuda1, Tsuyoshi Murata1, Aya Kanno1, Shun Yasuda1, Akiko Yamaguchi1, Rei Sekine2, Akihito Hata3, Keiya Fujimori1.   

Abstract

Cesarean scar pregnancy (CSP) is a rare complication involving the implantation of the gestational sac in a cesarean delivery scar. The authors report a case of unexpected placenta accreta spectrum (PAS) caused by late diagnosed CSP, necessitating emergent hysterectomy. A 28-year-old Japanese woman with two previous cesarean deliveries presented to our hospital at 11 weeks of gestation with abnormal transvaginal ultrasound findings obtained at another hospital;however, transabdominal ultrasound revealed that the fetus was already present in the uterine cavity at this time. At 28 weeks, there was no evidence of placenta previa. The woman developed preeclampsia at 29 weeks, and a cesarean section was conducted. Intraoperative findings confirmed PAS, and hysterectomy was conducted immediately.

Entities:  

Keywords:  cesarean scar pregnancy; late diagnosis; placenta accreta spectrum

Year:  2020        PMID: 32981904      PMCID: PMC7790469          DOI: 10.5387/fms.2020-14

Source DB:  PubMed          Journal:  Fukushima J Med Sci        ISSN: 0016-2590


Introduction

Cesarean scar pregnancy (CSP) is a rare complication involving the implantation of the gestational sac in a cesarean delivery scar[1)]. Because CSP is rare, its outcome with expectant management is not well known. Placenta accreta spectrum (PAS) is a significant obstetric complication that can cause massive and life-threatening bleeding. PAS is strongly associated with placenta previa[2)]. However, PAS may occur unexpectedly in the absence of placenta previa and not be diagnosed until delivery, necessitating emergent hysterectomy. Here, we present the case of a woman with CSP who later developed PAS without placenta previa. She was first diagnosed with PAS at the time of delivery and underwent emergent hysterectomy.

Case presentation

A 28-year-old Japanese woman, para 2 (two previous cesarean sections), presented to our hospital at 11 weeks of gestation because of potential CSP. At 9 weeks, she had undergone transvaginal ultrasound (TVUS) at another hospital, which showed the gestational sac to be positioned low in the uterus in the area of her previous cesarean scar. However, when the patient first presented to our hospital, transabdominal ultrasound could not clearly confirm CSP because there was no evidence of placenta preva and the fetus and placenta had grown toward and presented in the uterine cavity. As CSP could be neither confirmed nor ruled out, we opted to carefully monitor the perinatal conditions. At 28 weeks, TVUS showed placental attachment on the anterior wall with a distance between the placental margin and intra OS of at least 77 mm. Seeing no evidence of placenta previa, and we assumed PAS to be less likely (Fig. 1).
Fig 1.

Transvaginal ultrasound findings at 28 weeks. There is no evidence of placenta previa. The distance from the internal os to the margin of the placenta is 77.5 mm.

Transvaginal ultrasound findings at 28 weeks. There is no evidence of placenta previa. The distance from the internal os to the margin of the placenta is 77.5 mm. At 29 weeks of gestation, the woman was admitted because of preeclampsia. Magnesium sulfate was used to prevent seizures, and intramuscular steroid treatment was administered to stabilize fetal respiration after delivery. Despite strict perinatal management, the patient’s preeclampsia became more severe, with increased proteinuria. This prompted an emergent cesarean section at 30 weeks of gestation. At laparotomy, we observed medusa head infiltration of the uterine surface by the placenta along with bulging of the uterine wall, indicating the presence of PAS (Fig. 2). A baby weighing 1,534 g (Apgar scores 5 at 1 min and 7 at 5 min) was delivered through a transverse incision in the uterine fundus, and emergent cesarean hysterectomy was immediately conducted, with no attempt at placenta removal. The total blood loss was 1,370 mL, but maternal condition remained stable and no blood transfusion was required. The patient was discharged in good condition 8 days after the operation. Pathological examination showed villous tissue directly attached to the thin uterine wall, indicating abnormal placental invasion. There was no evidence of villous tissue invasion in the myometrium or uterine serosa (Fig. 3). Later, we obtained the patient’s 9-week ultrasound findings from the hospital she previously visited. These showed an empty uterine cavity and a gestational sac with fetal heartbeat in her cesarean scar (Fig. 4). Our final diagnosis was unexpected PAS caused by a late diagnosed CSP.
Fig 2.

Image taken during operation. Medusa head infiltration of the uterine surface by the placenta is observed, together with bulging of the anterior uterine wall.

Fig 3.

Histologic image of the resected uterine wall at the site of placental attachment. (A) The myometrium (arrow) maintains its original formation, although it is extremely thin, indicating CSP (hematoxylin-eosin stain, original magnification × 4). (B) Villous tissue (arrows) directly attached to the thin uterine wall without decidual tissue. Note no evidence of villous tissue invasion in the myometrium or uterine serosa. Placenta accreta was diagnosed (hematoxylin-eosin stain, original magnification × 10).

Fig 4.

Transvaginal ultrasound at 9 weeks performed at another hospital, indicating likely cesarean scar pregnancy. Note the gestational sac at the site of a previous cesarean scar.

Image taken during operation. Medusa head infiltration of the uterine surface by the placenta is observed, together with bulging of the anterior uterine wall. Histologic image of the resected uterine wall at the site of placental attachment. (A) The myometrium (arrow) maintains its original formation, although it is extremely thin, indicating CSP (hematoxylin-eosin stain, original magnification × 4). (B) Villous tissue (arrows) directly attached to the thin uterine wall without decidual tissue. Note no evidence of villous tissue invasion in the myometrium or uterine serosa. Placenta accreta was diagnosed (hematoxylin-eosin stain, original magnification × 10). Transvaginal ultrasound at 9 weeks performed at another hospital, indicating likely cesarean scar pregnancy. Note the gestational sac at the site of a previous cesarean scar.

Discussion

CSP is a rare form of ectopic pregnancy, accounting for 6.1% of ectopic pregnancies and 0.15% of pregnancies in women who have previously undergone CS[3,4)]. In most cases, CSP is diagnosed between 6 and 8 weeks of gestation because this is when the gestational sac is most clearly visible on ultrasound[5)]. Because CSP is rare, its obstetric outcome with expectant management is not well known. Recently, Cali et al.[6)] conducted a systematic review and meta-analysis of 52 expectantly managed cases of CSP. In 9.9% of cases (95% confidence interval [CI], 2.9-20.4%), uterine rupture occurred during the first or second trimester, and hysterectomy was required in 15.2% of cases (95% CI, 3.6-32.8%). A total of 40 cases (76.9% [95% CI, 65.4-68.5%]) progressed to the third trimester of pregnancy; in 74.8% of these (95% CI, 52.0-92.1%), PAS was diagnosed clinically or pathologically, with 69.7% of PAS cases (95% CI, 42.8-90.1%) being placenta percreta. These results suggest that CSP is a risk factor for PAS[1,6)]. PAS encompasses various degrees of pathologic adherence of the placenta, including placenta increta, placenta percreta, and placenta accreta. The most favored hypothesis regarding the etiology of PAS is the placenta adhering to a defective site in the decidua[7)]. Placenta previa in a patient with a history of CS is a strong risk factor for PAS. In such cases, careful diagnosis and multidisciplinary management strategies are required to reduce the risk of morbidity before CS[8)]. However, on occasion, PAS may be diagnosed for the first time at the time of delivery. Kyozuka et al.[9)] recently reported that undergoing CS two or more times, smoking during pregnancy, becoming pregnant through assisted reproductive technology, and uterine anomalies are all independent risk factors for unexpected PAS in the absence of placenta previa. Therefore, it is crucial to maintain a high index of suspicion for PAS during the antenatal period in patients with these risk factors, even without placenta previa. Many such patients have been clinically diagnosed with PAS, and these situations may require unexpected medical intervention, including manual removal of the adherent placenta, which can cause life-threatening postpartum hemorrhage[10)] and/or increased morbidity[11)]. CSPs are divided into two types based on imaging presentation and progression[12)]. In type 1 (endogenic CSP), the gestational sac grows toward the uterine cavity, and in type 2 (exogenic CSP), the gestational sac grows toward the bladder. In this case, although the gestational sac was observed in the area of the cesarean scar at 9 weeks, the diagnosis of CSP was delayed, and emergent cesarean hysterectomy was required because of unexpected PAS. We conclude that the present case was a type 1 CSP in which the placenta and fetus had already grown toward the uterine cavity, resulting in the absence of placenta previa and underestimation of the risk of PAS. Our experience shows that PAS can occur in the absence of placenta previa as a result of type 1 CSP. As the incidence of CSP appears to be rising[13)], type 1 CSP, in particular, may be increasing. Therefore, early diagnosis of CSP (between 6 and 8 weeks) is essential to ensure a high index of suspicion for unexpected PAS. It is important to suspect PAS if the placenta is present around a cesarean scar in the second to third trimester. This report illustrates the importance of ultrasound during early gestation in preventing the delayed diagnosis of CSP, which may result in unexpected PAS necessitating emergent hysterectomy.

Contributors

All authors were involved in the clinical care of the patient and contributed to the conception, drafting, review and revision of the manuscript. All authors saw and approved the final version of the paper and take full responsibility for the work.

Funding

This work did not receive any specific grant from funding agencies.

Patient Consent

Informed consent was obtained from the patients for publication of this work.

Provenance and Peer Review

This case report was peer reviewed.

Declaration of Competing Interest

The authors have no potential conflicts of interest to declare.
  13 in total

1.  Maternal morbidity associated with multiple repeat cesarean deliveries.

Authors:  Robert M Silver; Mark B Landon; Dwight J Rouse; Kenneth J Leveno; Catherine Y Spong; Elizabeth A Thom; Atef H Moawad; Steve N Caritis; Margaret Harper; Ronald J Wapner; Yoram Sorokin; Menachem Miodovnik; Marshall Carpenter; Alan M Peaceman; Mary J O'Sullivan; Baha Sibai; Oded Langer; John M Thorp; Susan M Ramin; Brian M Mercer
Journal:  Obstet Gynecol       Date:  2006-06       Impact factor: 7.661

Review 2.  Outcome of Cesarean scar pregnancy managed expectantly: systematic review and meta-analysis.

Authors:  G Calì; I E Timor-Tritsch; J Palacios-Jaraquemada; A Monteaugudo; D Buca; F Forlani; A Familiari; G Scambia; G Acharya; F D'Antonio
Journal:  Ultrasound Obstet Gynecol       Date:  2018-02       Impact factor: 7.299

Review 3.  Cesarean scar pregnancy is a precursor of morbidly adherent placenta.

Authors:  I E Timor-Tritsch; A Monteagudo; G Cali; A Vintzileos; R Viscarello; A Al-Khan; S Zamudio; P Mayberry; M M Cordoba; P Dar
Journal:  Ultrasound Obstet Gynecol       Date:  2014-07-31       Impact factor: 7.299

4.  Successful pregnancy located in a uterine cesarean scar: A case report.

Authors:  Shoko Tamada; Hisashi Masuyama; Jota Maki; Takeshi Eguchi; Takashi Mitsui; Eriko Eto; Kei Hayata; Yuji Hiramatsu
Journal:  Case Rep Womens Health       Date:  2017-03-23

5.  The clinical outcome of cesarean scar pregnancies implanted "on the scar" versus "in the niche".

Authors:  Andrea Kaelin Agten; Giuseppe Cali; Ana Monteagudo; Johana Oviedo; Joanne Ramos; Ilan Timor-Tritsch
Journal:  Am J Obstet Gynecol       Date:  2017-01-20       Impact factor: 8.661

Review 6.  Placenta previa, placenta accreta, and vasa previa.

Authors:  Yinka Oyelese; John C Smulian
Journal:  Obstet Gynecol       Date:  2006-04       Impact factor: 7.661

7.  Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach.

Authors:  Alireza A Shamshirsaz; Karin A Fox; Bahram Salmanian; Concepcion R Diaz-Arrastia; Wesley Lee; B Wycke Baker; Jerasimos Ballas; Qian Chen; Teelkien R Van Veen; Pouya Javadian; Haleh Sangi-Haghpeykar; Nicholas Zacharias; Stephen Welty; Christopher I Cassady; Amirhossein Moaddab; Edwina J Popek; Shiu-ki Rocky Hui; Jun Teruya; Venkata Bandi; Michael Coburn; Thomas Cunningham; Stephanie R Martin; Michael A Belfort
Journal:  Am J Obstet Gynecol       Date:  2014-08-27       Impact factor: 8.661

8.  Cesarean scar pregnancy: issues in management.

Authors:  K-M Seow; L-W Huang; Y-H Lin; M Yan-Sheng Lin; Y-L Tsai; J-L Hwang
Journal:  Ultrasound Obstet Gynecol       Date:  2004-03       Impact factor: 7.299

9.  Delayed diagnosis of a cesarean scar pregnancy: a case report.

Authors:  Eun Ju Jo; Hyun-Hwa Cha; Won Joon Seong
Journal:  J Med Case Rep       Date:  2019-03-07

10.  Risk factors for placenta accreta spectrum: findings from the Japan environment and Children's study.

Authors:  Hyo Kyozuka; Akiko Yamaguchi; Daisuke Suzuki; Keiya Fujimori; Mitsuaki Hosoya; Seiji Yasumura; Tadahiko Yokoyama; Akiko Sato; Koichi Hashimoto
Journal:  BMC Pregnancy Childbirth       Date:  2019-11-27       Impact factor: 3.007

View more
  1 in total

1.  Introduction and utility of resuscitative endovascular balloon occlusion of the aorta for cases with a potential high risk of postpartum hemorrhage: A single tertiary care center experience of two cases.

Authors:  Hyo Kyozuka; Misa Sugeno; Tsuyoshi Murata; Toki Jin; Fumihiro Ito; Yasuhisa Nomura; Takaki Hirano; Kazuaki Shinohara; Daisuke Suzuki; Tokiya Ishida
Journal:  Fukushima J Med Sci       Date:  2022-04-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.